Double dealing with your data. КОРЗИНА ПОИСК НАВИГАТОР ЖУРНАЛЫ КНИГИ ПАТЕНТЫ
ПОИСК АВТОРЫ ОРГАНИЗАЦИИ КЛЮЧЕВЫЕ СЛОВА РУБРИКАТОР Начальная страница …

Unlocking the datasets. КОРЗИНА ПОИСК НАВИГАТОР ЖУРНАЛЫ КНИГИ ПАТЕНТЫ
ПОИСК АВТОРЫ ОРГАНИЗАЦИИ КЛЮЧЕВЫЕ СЛОВА РУБРИКАТОР Начальная …

Discusses ethical dilemmas associated with randomized clinical trials. The extent of
knowledge of the safety monitoring protocol in a trial; Whether clinical investigators should …

What is medicine for? One answer is that medicine is to cure disease. But definitions of
disease vary. Disease can be recognised by the doctor and the patient (mumps), by the …

The importance of transparency and data sharing in clinical research is increasingly
emphasised, and public funders increasingly require that all data from publicly sponsored …

Sir—We were surprised to find a reference to the UK Biobank in your Apr 24 Editorial (p
1335) 1 on the dangers of selective reporting of clinical trials by the pharmaceutical industry …

The Lancet has been threatened with legal action on two occasions during the past month or
so. Since none of our editorial staff seem especially keen to go to court, let alone see the …

I regulatory authorities, 5 or because of internal evidence from interim analyses. 6 A major
change can lead to suspension of randomisation, 6 to already-randomised patients being …

Sir—As Iain Chalmers and Douglas Altman (Feb 6, p 490) 1 point out, a systematic
approach is long overdue to prevent poor medical research not only during and at the end of …

We thank the correspondents for their responses to our Comment. 1 Although randomised
controlled trials (RCTs) that are rigorously designed, conducted, and analysed provide …